OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Biography

A.S. Singh has is presently working as postdoctoral fellow in Dr. Axel Brockmann’s Lab at NCBS. He completed his Ph. D research in May 2013 in the University of Calcutta under the supervision of Dr. Usha Rajamma. His main research interest is to understand the mechanism of how genes regulate behaviors through certain neural circuitry systems.

Abstract

One of the most consistent finding in ASD research is the presence of high serotonin level in the blood platelets of 30% ASD subpopulations. Abnormal serotonin synthesis capacity has also been implicated in the brain of ASD individuals. Even though serotonergic pathway in brain and the periphery is differentially regulated, during early stage of life when the blood brain barrier is not fully formed, the only rate limiting enzyme available for serotonin biosynthesis is the peripherally expressed TPH1 which is the isoform of brain specific TPH2. On the light of these evidences the present study is a thorough investigation of TPH1 gene to find the risk locus for serotonergic abnormality in ASD. From the family based approaches with individual markers, we found that A allele of rs10488682 is significantly overtransmitted from parent to female probands. Two-locus haplotype analyses showed significant overtransmission with various combinations of different SNPs that include rs623580, rs1800532, rs684302, rs1799913, rs211106 and rs10488682. Similar observation was also found with three locus haplotype models. Functional prediction analysis illustrated polymorphisms of these markers have very low to moderate effect on the gene regulation.
Investigation with platelet serotonin assay showed that 33% of ASD individuals are hyperserotoninemic in our study population in India and is very close to the earlier reports of 30% (approx). Furthermore, quantitative trait association analyses with specific alleles, genotypes and haplotypes also demonstrated involvement of rs684302, rs211106, rs1800532 and rs1799913 of TPH1 in the increased platelet serotonin level of ASD. Thus our various approaches with genetic association studies and genotype-phenotype correlation analyses suggest involvement of TPH1 in the pathophysiology of ASD through the regulation of serotonin level. Since we do not have the functional experimental data, our findings provide the preliminary evidences. However, these data highlight the need of extensive research both in genetic and functional level for clear understating of TPH1 involvement in the etiology of ASD.